Morgan Stanley’s Monopar Therapeutics MNPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Buy |
7,932
+6,508
| +457% | +$233K | ﹤0.01% | 5712 |
|
|
2025
Q1 | $51.8K | Sell |
1,424
-2,377
| -63% | -$86.5K | ﹤0.01% | 6254 |
|
|
2024
Q4 | $83.6K | Buy |
+3,801
| New | +$83.6K | ﹤0.01% | 6127 |
|
|
2024
Q2 | – | Sell |
-800
| Closed | -$545 | – | 7925 |
|
|
2024
Q1 | $545 | Sell |
800
-800
| -50% | -$545 | ﹤0.01% | 7233 |
|
|
2023
Q4 | $544 | Buy |
1,600
+800
| +100% | +$272 | ﹤0.01% | 7274 |
|
|
2023
Q3 | $496 | Sell |
800
-3,200
| -80% | -$1.98K | ﹤0.01% | 7308 |
|
|
2023
Q2 | $3.42K | Hold |
4,000
| – | – | ﹤0.01% | 7068 |
|
|
2023
Q1 | $5.56K | Hold |
4,000
| – | – | ﹤0.01% | 7026 |
|
|
2022
Q4 | $9.48K | Hold |
4,000
| – | – | ﹤0.01% | 6957 |
|
|
2022
Q3 | $6K | Hold |
4,000
| – | – | ﹤0.01% | 7210 |
|
|
2022
Q2 | $9K | Sell |
4,000
-3
| -0.1% | -$7 | ﹤0.01% | 7247 |
|
|
2022
Q1 | $10K | Buy |
4,003
+2
| +0% | +$5 | ﹤0.01% | 7402 |
|
|
2021
Q4 | $13K | Buy |
4,001
+1
| +0% | +$3 | ﹤0.01% | 7381 |
|
|
2021
Q3 | $19K | Hold |
4,000
| – | – | ﹤0.01% | 7117 |
|
|
2021
Q2 | $24K | Buy |
4,000
+800
| +25% | +$4.8K | ﹤0.01% | 6944 |
|
|
2021
Q1 | $20K | Hold |
3,200
| – | – | ﹤0.01% | 6717 |
|
|
2020
Q4 | $20K | Hold |
3,200
| – | – | ﹤0.01% | 6435 |
|
|
2020
Q3 | $17K | Hold |
3,200
| – | – | ﹤0.01% | 6116 |
|
|
2020
Q2 | $24K | Hold |
3,200
| – | – | ﹤0.01% | 5961 |
|
|
2020
Q1 | $23K | Sell |
3,200
-7,432
| -70% | -$53.4K | ﹤0.01% | 5757 |
|
|
2019
Q4 | $177K | Buy |
+10,632
| New | +$177K | ﹤0.01% | 5460 |
|